News for hackers. Stuff that matters.
Re:In China, Desperate Patients Smuggle Drugs or Make Their Own by averros on Monday November 12, 2018 @04:25PM (#18435998)
That's what you get if your governments give monopoly on making drugs to huge corporations. Patens and enormously costly "approvals" (rather than strict liability) are the root of the problem.
Re:In China, Desperate Patients Smuggle Drugs or Make Their Own by Scoundreller on Monday November 12, 2018 @04:30PM (#18436048)
I don't think we'd have 99% of these novel clinical compounds if it weren't for patents.

As for approvals, I don't know why we have each country doing its own approvals, instead of international groups that individuals can choose whether they want to trust or not. Are Europeans sufficiently different than Chinese, Indians, Australians, Canadians, Germans or Americans to warrant independent safety approvals?

If they're using different metrics to process approvals, why? Shouldn't the same inputs result in the same outputs?

Re:In China, Desperate Patients Smuggle Drugs or Make Their Own by BurningFrog on Monday November 12, 2018 @07:09PM (#18437173)
If approvals were about science, one approval would be good enough worldwide.

In reality, approvals are also about politics.

Re:In China, Desperate Patients Smuggle Drugs or Make Their Own by refurb on Monday November 12, 2018 @09:30PM (#18437948)
Well, considering the US avoided the thalidomide tragedy because they decided approval in Europe was t good enough, you’re unlikely to see a scenario where it gets approved simply because someone else approved it.
Re:In China, Desperate Patients Smuggle Drugs or Make Their Own by baud147258 on Tuesday November 13, 2018 @04:39AM (#18439785)
The thalidomide tragedy didn't happen in France too, because of a new law adding stricter controls on drugs.
Re:In China, Desperate Patients Smuggle Drugs or Make Their Own by spectrum1234 on Monday November 12, 2018 @05:41PM (#18436672)
Why wouldn't these compounds evolve to be open source? Barriers to entry wouldn't be billions in R&D if every stepping stone was open sourced.
Re:In China, Desperate Patients Smuggle Drugs or Make Their Own by pkaye on Monday November 12, 2018 @06:12PM (#18436869)
The real question is who will pay for testing drug safety and efficacy.

Take Auryxia which is literally ferric citrate. Its used by kidney patients to control phosphorus levels and boost iron. Why did it take so long to get tested and approved as a drug when the formula was "open source" for a long time? Well one company did the time and effort and suddenly it is considered a valuable drug. The value came from proving the safety and efficacy and someone has to be willing to fund it.

Re:In China, Desperate Patients Smuggle Drugs or Make Their Own by Retric on Monday November 12, 2018 @07:00PM (#18437126)
Drug tests are not inherently that expensive. FDA trials run about 1% of the cost of each new drug. https://www.jhsph.edu/news/news-releases/2018/cost-of-clinic...

The long line of failed drugs are the real issue.

Re:In China, Desperate Patients Smuggle Drugs or Make Their Own by refurb on Monday November 12, 2018 @09:35PM (#18437971)
No offense but the article you referenced is misleading.

Sure, just the trial might cost that little if it’s an orphan disease, but it’s also ignoring all the other stuff that goes along with running a trial. Things like manufacturing, compliance, data analysis, etc.

When you look at the total cost of R&D for a drug, it’s typically 1/3 for discovery and 2/3 for development (clinical trials).

If your drug is used in any reasonable sized population, development is easily in the hundreds of millions of dollars.

You are correct about the failure rates though.

Re:In China, Desperate Patients Smuggle Drugs or Make Their Own by darawk on Monday November 12, 2018 @06:00PM (#18436794)
...and what do you think you get if you don't do those things? The answer is no drugs at all.
Re:In China, Desperate Patients Smuggle Drugs or Make Their Own by averros on Tuesday November 13, 2018 @03:23AM (#18439503)
This is totally false, as there are other parties which are interested in developing new drugs: academic researchers, insurance companies, and patients. The drug research is paid for by patients and insured as it stands now, but the FDA/pharma cartel monopolized drug development using patents and the hugely expensive approval process. Now, pharmas are interested in profitable drugs which don't as much cure the diseases but rather allow mainenance of chronic conditions for years and years. Actual effective cures are not a priority. Interests of insurers and patients are quute different: they would love quick, cheap, and effective cures. It's all about incentives.
Re:In China, Desperate Patients Smuggle Drugs or Make Their Own by darawk on Tuesday November 13, 2018 @12:15PM (#18442654)
> This is totally false, as there are other parties which are interested in developing new drugs: academic researchers, insurance companies, and patients.

Why would an insurance company be interested in developing new drugs? Health insurance companies don't lose money if you die.

How do you propose that academic researchers fund their work, all the way through the approval point?

> The drug research is paid for by patients and insured as it stands now, but the FDA/pharma cartel monopolized drug development using patents and the hugely expensive approval process.

Do you think the process is expensive because of the pharma companies, or do you think the pharma companies are the way they are because the process is expensive?

> Now, pharmas are interested in profitable drugs which don't as much cure the diseases but rather allow mainenance of chronic conditions for years and years. Actual effective cures are not a priority.

This is a thing people say, but it's not really true. It'd be great if all you had to do to create more cures was snap your fingers and change the incentive structure. But the fact of the matter is that cures are harder to create. Incremental improvements are easier. So you get more of them. Pharma companies do in fact still cure things when they can, see the recent HepC cure.

Re:In China, Desperate Patients Smuggle Drugs or Make Their Own by claudiawerner on Monday November 12, 2018 @08:26PM (#18437616)
Is it? I remember seeing a paper in which they found no empirical evidence that patents actually help in medicine. I'd be interested to know if you have any information on it.
Re:In China, Desperate Patients Smuggle Drugs or Make Their Own by darawk on Tuesday November 13, 2018 @12:16PM (#18442662)
I'm not sure how that could be the case. I'm not familiar with that paper, but I would be curious to see its logic. It's hard to imagine that completely removing the financial incentive to create a thing would engender more of that thing.
Re:In China, Desperate Patients Smuggle Drugs or Make Their Own by pkaye on Monday November 12, 2018 @06:02PM (#18436804)
What country has had success with using the strict liability approach?